youtube_live
Q3 2026 earnings • released • EPS beat +7,77% • Revenue beat +2,95%
See resultschevron_right
GH:NASDAQ
Guardant Health Inc
153,43 USD
arrow_downward
-8,99%(-15,15) 1D
143,00 USD
arrow_downward
-6,80% (-10,43)todayPre-market
Closed: 5-ноя., 16:00:02 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
165,00 USD
High
165,10 USD
Low
151,92 USD
Mkt. cap
20,59 млд
Avg. vol.
1,81 млн
Volume
8,46 миң
52-wk high
191,01 USD
52-wk low
74,55 USD
EPS
-3,50 USD
Beta
1,67
Shares outstanding
134,20 млн
No. of employees
2 миң
Open
165,00 USD
High
165,10 USD
Low
151,92 USD
Mkt. cap
20,59 млд
Avg. vol.
1,81 млн
Volume
8,46 миң
52-wk high
191,01 USD
52-wk low
74,55 USD
EPS
-3,50 USD
Beta
1,67
Shares outstanding
134,20 млн
No. of employees
2 миң
News stories
From web sources and news partners
Investing.com
·
1 саат мурун
Guardant Health stock reiterated at Buy by BTIG after Q3 beat
GenomeWeb
·
11 саат мурун
Guardant Health Q3 Revenue Climbs 36 Percent as Firm Raises Full-Year Guidance
Zacks
·
11 саат мурун
Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates
Securities.io
·
11 саат мурун
Guardant Health Lifts 2026 Revenue Outlook as Screening Surges
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 миң
Founded2012
HeadquartersПало Альто, Калифорния, Америка Кошмо Штаттары
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com